Russel Krawitz1, Anthony Glover2,3, Sireesha Koneru2, James Jiang2, Aimee Di Marco2, Anthony J Gill2,3,4,5, Ahmad Aniss2, Mark Sywak2,3, Leigh Delbridge2,3, Stan Sidhu2,3. 1. University of Sydney Endocrine Surgical Unit, Royal North Shore Hospital, Northern Sydney Local Health District, Sydney, NSW, Australia. russelkrawitz@gmail.com. 2. University of Sydney Endocrine Surgical Unit, Royal North Shore Hospital, Northern Sydney Local Health District, Sydney, NSW, Australia. 3. Northern Clinical School, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. 4. NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia. 5. Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, NSW, Australia.
Abstract
INTRODUCTION: We investigated outcomes in a cohort of patients with a biochemical diagnosis of primary hyperparathyroidism (pHPT) undergoing surgery for asymptomatic disease or target organ damage, where a focussed or four-gland operation was undertaken and the histopathology only reported a "large normal" parathyroid gland (LNP). METHODS AND MATERIALS: Patients subjected to a parathyroidectomy for pHPT between 2012 and 2018 with a pathology of LNP were included. Patients with fat depletion or additional histological features of adenoma or hyperplasia in any of the resected glands were excluded. A control group was formed from 50 consecutive patients with the histological finding of adenoma or hyperplasia during the same study period. The primary outcome was biochemical normalisation of pHPT at 1-2 weeks and after 6 months post-operatively. RESULTS: Forty-eight LNP patients (2% of all parathyroidectomies) were included in the study group with 50 matched controls. LNP patients had a lower biochemical cure rate (81% vs. 98% P < 0.05) and a higher risk of recurrence (10% vs. 0%, P = 0.06). LNP patients had a milder form of pHPT (Ca2+ 2.63 vs. 2.68 P < 0.05) with a smaller PTH and Ca2+ drop post-operatively. For LNP patients with failure, a definite additional cause of pHPT was found in only two patients. CONCLUSION: This study highlights a controversial area in pHPT and reports LNP as a cause of pHPT. The biochemical analysis of this LNP group supports a benefit in resection in the setting of pHPT, although the risk of failure (persistence/recurrence) is higher than those with adenoma or hyperplasia. Stricter post-operative follow-up of LNP patients should be considered.
INTRODUCTION: We investigated outcomes in a cohort of patients with a biochemical diagnosis of primary hyperparathyroidism (pHPT) undergoing surgery for asymptomatic disease or target organ damage, where a focussed or four-gland operation was undertaken and the histopathology only reported a "large normal" parathyroid gland (LNP). METHODS AND MATERIALS: Patients subjected to a parathyroidectomy for pHPT between 2012 and 2018 with a pathology of LNP were included. Patients with fat depletion or additional histological features of adenoma or hyperplasia in any of the resected glands were excluded. A control group was formed from 50 consecutive patients with the histological finding of adenoma or hyperplasia during the same study period. The primary outcome was biochemical normalisation of pHPT at 1-2 weeks and after 6 months post-operatively. RESULTS: Forty-eight LNP patients (2% of all parathyroidectomies) were included in the study group with 50 matched controls. LNP patients had a lower biochemical cure rate (81% vs. 98% P < 0.05) and a higher risk of recurrence (10% vs. 0%, P = 0.06). LNP patients had a milder form of pHPT (Ca2+ 2.63 vs. 2.68 P < 0.05) with a smaller PTH and Ca2+ drop post-operatively. For LNP patients with failure, a definite additional cause of pHPT was found in only two patients. CONCLUSION: This study highlights a controversial area in pHPT and reports LNP as a cause of pHPT. The biochemical analysis of this LNP group supports a benefit in resection in the setting of pHPT, although the risk of failure (persistence/recurrence) is higher than those with adenoma or hyperplasia. Stricter post-operative follow-up of LNP patients should be considered.
Authors: Olov Norlén; Kuan Chi Wang; Yeng Kwang Tay; William R Johnson; Simon Grodski; Meei Yeung; Jonathan Serpell; Stan Sidhu; Mark Sywak; Leigh Delbridge Journal: Ann Surg Date: 2015-05 Impact factor: 12.969
Authors: David F Schneider; Jocelyn F Burke; Kristin A Ojomo; Nicholas Clark; Haggi Mazeh; Rebecca S Sippel; Herbert Chen Journal: Ann Surg Oncol Date: 2013-08-14 Impact factor: 5.344
Authors: Anthony J Gill; Grace Lim; Veronica K Y Cheung; Juliana Andrici; Joanna L Perry-Keene; Julie Paik; Loretta Sioson; Adele Clarkson; Amy Sheen; Catherine Luxford; Marianne S Elston; Goswin Y Meyer-Rochow; M Teresa Nano; Schelto Kruijff; Anton F Engelsman; Mark Sywak; Stanley B Sidhu; Leigh W Delbridge; Bruce G Robinson; Deborah J Marsh; Christopher W Toon; Angela Chou; Roderick J Clifton-Bligh Journal: Am J Surg Pathol Date: 2019-01 Impact factor: 6.394
Authors: Ji-Eun Lee; Namki Hong; Jin Kyong Kim; Cho Rok Lee; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Yumie Rhee Journal: Ann Surg Treat Res Date: 2022-07-07 Impact factor: 1.766